Sumitomo Mitsui Trust Group Inc. Has $6.97 Million Holdings in Quantum-Si Incorporated (NASDAQ:QSI)

Sumitomo Mitsui Trust Group Inc. reduced its stake in shares of Quantum-Si Incorporated (NASDAQ:QSI - Free Report) by 2.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,811,430 shares of the company's stock after selling 153,778 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 3.17% of Quantum-Si worth $6,974,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in QSI. Rhumbline Advisers raised its stake in shares of Quantum-Si by 3.7% in the 4th quarter. Rhumbline Advisers now owns 148,946 shares of the company's stock valued at $402,000 after acquiring an additional 5,298 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in Quantum-Si in the 4th quarter valued at $95,000. Bank of New York Mellon Corp grew its stake in Quantum-Si by 21.3% in the 4th quarter. Bank of New York Mellon Corp now owns 269,807 shares of the company's stock valued at $728,000 after buying an additional 47,400 shares during the last quarter. SBI Securities Co. Ltd. acquired a new stake in shares of Quantum-Si in the fourth quarter valued at about $60,000. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Quantum-Si by 32.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 308,021 shares of the company's stock valued at $832,000 after purchasing an additional 75,661 shares during the last quarter. 39.90% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Alliance Global Partners reaffirmed a "buy" rating on shares of Quantum-Si in a report on Friday, May 16th. HC Wainwright restated a "buy" rating and issued a $5.50 price target on shares of Quantum-Si in a research report on Monday, May 19th.

Insider Buying and Selling

In related news, insider John S. Vieceli sold 21,923 shares of the business's stock in a transaction on Monday, June 23rd. The stock was sold at an average price of $1.61, for a total value of $35,296.03. Following the sale, the insider owned 842,586 shares of the company's stock, valued at $1,356,563.46. The trade was a 2.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jeffrey Alan Hawkins sold 23,705 shares of the business's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total transaction of $38,165.05. Following the completion of the sale, the chief executive officer owned 2,623,011 shares in the company, valued at $4,223,047.71. This represents a 0.90% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 54,252 shares of company stock worth $87,346 over the last ninety days. Company insiders own 22.95% of the company's stock.

Quantum-Si Stock Performance

Shares of NASDAQ:QSI traded down $0.31 during trading on Monday, hitting $1.83. 16,535,926 shares of the stock were exchanged, compared to its average volume of 11,315,023. Quantum-Si Incorporated has a 1-year low of $0.61 and a 1-year high of $5.77. The company has a market capitalization of $335.81 million, a price-to-earnings ratio of -2.69 and a beta of 2.89. The company's fifty day simple moving average is $1.66 and its 200-day simple moving average is $1.74.

Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.11) earnings per share for the quarter, topping analysts' consensus estimates of ($0.17) by $0.06. Quantum-Si had a negative net margin of 2,925.41% and a negative return on equity of 41.44%. The firm had revenue of $0.84 million for the quarter, compared to the consensus estimate of $0.96 million. On average, research analysts forecast that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Quantum-Si Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.